Cargando…

Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy

BACKGROUND: Interatrial block (IAB) has been associated with supraventricular arrhythmias and stroke, and even with sudden cardiac death in the general population. Whether IAB is associated with life‐threatening arrhythmias (LTA) and sudden cardiac death in dilated cardiomyopathy (DCM) remains unkno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henkens, Michiel T. H. M., López Martínez, Helena, Weerts, Jerremy, Sammani, Arjan, Raafs, Anne G., Verdonschot, Job A. J., van de Leur, Rutger R., Sikking, Maurits A., Stroeks, Sophia, van Empel, Vanessa P. M., Brunner‐La Rocca, Hans‐Peter, van Stipdonk, Antonius M. W., Farmakis, Dimitrios, Hazebroek, Mark R., Vernooy, Kevin, Bayés‐de‐Luna, Antoni, Asselbergs, Folkert W., Bayés‐Genís, Antoni, Heymans, Stephane R. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707810/ https://www.ncbi.nlm.nih.gov/pubmed/35861818 http://dx.doi.org/10.1161/JAHA.121.025473

Ejemplares similares

Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis
por: Bayés de Luna, Antoni, et al.
Publicado: (2017)

Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
por: Sikking, Maurits A., et al.
Publicado: (2023)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Diagnosis of interatrial block
por: Bayés de Luna, Antoni, et al.
Publicado: (2017)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Second-Degree Interatrial Block in Hemodialysis Patients
por: Enriquez, Andres, et al.
Publicado: (2015)

Clustering of Cardiac Transcriptome Profiles Reveals Unique: Subgroups of Dilated Cardiomyopathy Patients
por: Verdonschot, Job A.J., et al.
Publicado: (2023)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
por: Bayes-Genis, Antoni
Publicado: (2022)

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
por: Díez, Javier, et al.
Publicado: (2017)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

Translational proteomics in cardiogenic shock: from benchmark to bedside
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Life-threatening ventricular arrhythmia prediction in patients with dilated cardiomyopathy using explainable electrocardiogram-based deep neural networks( )
por: Sammani, Arjan, et al.
Publicado: (2022)

Can Natriuretic Peptides be Used to Guide Therapy?
por: Bayes-Genis, Antoni, et al.
Publicado: (2016)

Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study
por: Raafs, Anne G., et al.
Publicado: (2023)

Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross‐over study
por: Weerts, Jerremy, et al.
Publicado: (2023)

Bioluminescence imaging: a shining future for cardiac regeneration
por: Roura, Santiago, et al.
Publicado: (2013)

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
por: Verdonschot, Job A.J., et al.
Publicado: (2021)

Acute Coronary Syndromes in 2011 and 2012
por: Sanchis, Juan, et al.
Publicado: (2013)

In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin’
por: Perea-Gil, Isaac, et al.
Publicado: (2015)

Epigenetic Biomarkers in Cardiovascular Diseases
por: Soler-Botija, Carolina, et al.
Publicado: (2019)

Persistent chest pain after recovery of COVID-19: microvascular disease-related angina?
por: Vallejo, Nuria, et al.
Publicado: (2021)

Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial
por: Hazebroek, Mark R., et al.
Publicado: (2021)

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
por: Henkens, M. T. H. M., et al.
Publicado: (2022)

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
por: Barandiarán Aizpurua, Arantxa, et al.
Publicado: (2021)

The role and potential of umbilical cord blood in an era of new therapies: a review
por: Roura, Santiago, et al.
Publicado: (2015)

Impact of Umbilical Cord Blood-Derived Mesenchymal Stem Cells on Cardiovascular Research
por: Roura, Santiago, et al.
Publicado: (2015)

Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era
por: Altisent, Omar Abdul-Jawad, et al.
Publicado: (2020)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
por: Roura, Santiago, et al.
Publicado: (2017)

A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials
por: Jahn-Eimermacher, Antje, et al.
Publicado: (2017)

Editorial: The Role of Sex in Heart Failure and Transplantation
por: Martínez-Sellés, Manuel, et al.
Publicado: (2021)

Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites
por: Courageux, Yvan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rj0cmpf514olipb4regcokdb2t